Related Experiment Video
Updated: Jul 29, 2025

Primary Culture of Rat Adrenocortical Cells and Assays of Steroidogenic Functions
Published on: March 12, 2019
What is the role of CHCHD2 in adrenal tumourigenesis?
Angeliki Karapanagioti1,2, Narjes Nasiri-Ansari1, Athanasios Moustogiannis3
1Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Purpose:
CHCHD2 is an antiapoptotic mitochondrial protein acting through the BCL2/BAX pathway in various cancers. However, data on the regulatory role of CHCHD2 in adrenal tumourigenesis are scarce.
Methods:
We studied the expression of CHCHD2, BCL2, and BAX in human adrenocortical tissues and SW13 cells. mRNA and protein levels were analyzed through qPCR and immunoblotting, respectively, in 16 benign adrenocortical neoplasms (BANs), along with their adjacent normal adrenal tissues (controls), and 10 adrenocortical carcinomas (ACCs). BCL2/BAX mRNA expression was also analyzed in SW13 cells after CHCHD2 silencing. MTS, flow cytometry and scratch assays were performed to assess cell viability, apoptosis, and invasion, respectively.
Results:
BCL2 and CHCHCD2 mRNA and protein expression was increased in BANs compared to normal adrenal tissues whereas BAX was decreased. BAX and CHCHD2 mRNA and protein levels were significantly downregulated and upregulated, respectively, in ACCs compared with either BANs or controls. Expression of the studied genes was not different among cortisol-secreting and nonfunctional ACAs. No significant association was found between genes' expression and other established prognostic markers of ACCs patients. In vitro analysis showed that CHCHD2 silencing resulted in reduced cell viability and invasion as well as increased SW13 cells apoptosis.
Conclusions:
CHCHD2 expression seems to be implicated in adrenal tumourigenesis and its absence resulted to increased apoptosis in vitro. However, the exact mechanism of action and particularly its association with the BAX/BCL2 pathway needs to be further studied and evaluate whether it could be a protentional therapeutic target.
Insights
The mitochondrial protein CHCHD2 is upregulated in benign adrenal tumors but downregulated in carcinomas. Its absence increases cancer cell apoptosis, suggesting CHCHD2 as a potential therapeutic target in adrenal tumorigenesis.
Area of Science:
- Endocrinology
- Oncology
- Molecular Biology
Background:
- The antiapoptotic mitochondrial protein CHCHD2 (coiled-coil-helix-domain-containing protein 2) plays a role in the BCL2/BAX pathway in various cancers.
- Data regarding the specific role of CHCHD2 in adrenal gland tumor development (adrenal tumourigenesis) are limited.
Purpose of the Study:
- To investigate the expression of CHCHD2 and its association with BCL2 and BAX in human adrenocortical tissues.
- To explore the functional impact of CHCHD2 on adrenal cancer cell behavior in vitro.
Main Methods:
- Quantitative PCR (qPCR) and immunoblotting were used to analyze mRNA and protein levels of CHCHD2, BCL2, and BAX.
- Expression analysis was performed on human benign adrenocortical neoplasms (BANs), adrenocortical carcinomas (ACCs), and adjacent normal adrenal tissues.
- In vitro studies involved CHCHD2 gene silencing in SW13 cells, followed by assays for cell viability, apoptosis, and invasion.
Main Results:
- CHCHD2 and BCL2 mRNA and protein levels were elevated in BANs compared to normal tissues, while BAX was decreased.
- In ACCs, both BAX and CHCHD2 showed significant downregulation and upregulation, respectively, compared to BANs and controls.
- CHCHD2 silencing in SW13 cells led to decreased cell viability and invasion, alongside increased apoptosis.
Conclusions:
- CHCHD2 expression appears to be involved in adrenal tumourigenesis.
- The absence of CHCHD2 promotes apoptosis in adrenal cancer cells in vitro.
- Further research is needed to elucidate the precise mechanism of CHCHD2 action, particularly its interaction with the BAX/BCL2 pathway, to assess its potential as a therapeutic target.
Related Concept Videos
Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Abnormal Proliferation
Hormones of the Adrenal Glands
The adrenal cortex, a powerhouse of hormone synthesis, generates over two dozen corticosteroid hormones. The zona glomerulosa produces mineralocorticoids, exemplified by aldosterone, influencing the electrolyte composition of body fluids. The synthesis of glucocorticoids such as cortisol and...
Anatomy of the Adrenal Glands
These glands possess a distinctive yellow tinge due to the stored cholesterol and fatty acids required for hormone synthesis. They are encased in a fibrous capsule and cushioned by fat.
The adrenal gland comprises two distinct...
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Hedgehog Signaling Pathway

